LEX-WK-GG0SCV1Xcrawled 2022-07-22 13:51Z
FDA issued guidance on statistical considerations for clinical trials during the COVID-19 public health emergency
John D. Kendzior · Ryan Pate · Health Industry Washington Watch · Published June 19, 2020
Work details
- author
- John D. Kendzior · Ryan Pate
- firm or organization
- Reed Smith LLP
- publication
- Health Industry Washington Watch
- practice area
- Health Care and Life Sciences
- published
- 2020-06-19
Citation
John D. Kendzior, Ryan Pate, FDA issued guidance on statistical considerations for clinical trials during the COVID-19 public health emergency, Health Industry Washington Watch (June 19, 2020) [The Library at LexBlog, LEX-WK-GG0SCV1X, lexpid.org/GG0SCV1X]